Galileo Secures $45 Million in Series B Funding to Revolutionize Healthcare Delivery

Galileo, a pioneering team-based medical practice dedicated to enhancing the quality and affordability of healthcare, has announced a successful funding round, raising a remarkable $45 million. Founded by Dr. Tom X. Lee, who is renowned for his groundbreaking work with One Medical and Epocrates, Galileo operates across all 50 states, providing high-touch, data-driven, multi-specialty, longitudinal care tailored to meet the needs of diverse and complex patients. The funding will be pivotal in supporting Galileo's mission to improve population health by expanding its innovative approach to healthcare delivery. This round of investment will enable the company to enhance its technological infrastructure, foster deeper connections between patients and providers, and continue developing solutions that address the most significant challenges in the healthcare system today. With the backing of regional and national health plans, employers, and Fortune 500 companies, Galileo is positioned as a leading solution for improving healthcare outcomes. The infusion of capital will not only help expand their services but also solidify their commitment to making quality healthcare accessible to everyone, regardless of their location or complexity of needs. As they embark on this next phase of growth, Galileo remains focused on transforming the healthcare landscape, proving that innovation, compassion, and a commitment to teamwork can lead to significant improvements in patient care.